• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴水肿和脂肪性水肿患者的静脉血栓栓塞结局:来自全国住院患者样本的分析。

Venous thromboembolic outcomes in patients with lymphedema and lipedema: An analysis from the National Inpatient Sample.

作者信息

Khalid Muhammad Umar, Prasada Sameer, Jennings Courtney, Bartholomew John R, McCarthy Meghann, Hornacek Deborah A, Joseph Douglas, Chen Wei, Schwarz Graham, Bhandari Rohan, Elbadawi Ayman, Cameron Scott J

机构信息

Section of Vascular Medicine, Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.

Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.

出版信息

Vasc Med. 2024 Feb;29(1):42-47. doi: 10.1177/1358863X231219006.

DOI:10.1177/1358863X231219006
PMID:38334096
Abstract

BACKGROUND

Patients with lymphedema and lipedema share physical exam findings that may lead to misdiagnosis. Poor mobility is common in patients with obesity and patients with lymphedema and lipedema. This may constitute a risk factor for venous thromboembolism (VTE). Our objective was to evaluate the association of VTE in obese patients with lymphedema and lipedema.

METHODS

The National Inpatient Sample (NIS) was searched from 2016 to 2020 to identify hospital admissions of obese female patients with lymphedema and lipedema. Patients were analyzed in the context of presence or absence of VTE while adjusting for complex cluster sampling techniques. Predictors of VTE were accessed by multivariable regression.

RESULTS

Lymphedema was identified in 189,985 patients and lipedema in 50,645 patients. VTE was observed in 3.12% ( = 374,210) of patients with obesity. In patients with obesity, VTE was more common in patients with lymphedema than without (2.6% vs 1.6%; < 0.01). Similarly, VTE was more common in patients with lipedema than without (0.6% vs 0.4%; < 0.01). After multivariable logistic regression, VTE events in obese patients with lymphedema were higher versus without (OR 1.6; CI 1.08-2.43; = 0.02). Similarly, VTE events were more common in obese patients with lipedema versus obese patients without lipedema (OR 1.20; CI 1.03-1.41; = 0.02).

CONCLUSIONS

In this hypothesis-generating study, lymphedema and lipedema show a positive association with VTE after adjusting for baseline patient characteristics such as obesity, which is a known independent risk factor for VTE. Mechanisms whereby lymphedema and lipedema are associated with VTE should be investigated.

摘要

背景

淋巴水肿和脂肪性水肿患者的体格检查结果可能导致误诊。肥胖患者以及淋巴水肿和脂肪性水肿患者普遍存在行动不便的情况。这可能构成静脉血栓栓塞(VTE)的一个危险因素。我们的目的是评估肥胖合并淋巴水肿和脂肪性水肿患者中VTE的相关性。

方法

检索2016年至2020年的全国住院患者样本(NIS),以确定肥胖女性淋巴水肿和脂肪性水肿患者的住院情况。在调整复杂整群抽样技术的情况下,对患者进行有无VTE的分析。通过多变量回归分析VTE的预测因素。

结果

共识别出189,985例淋巴水肿患者和50,645例脂肪性水肿患者。肥胖患者中观察到VTE的比例为3.12%(n = 374,210)。在肥胖患者中,淋巴水肿患者发生VTE的情况比无淋巴水肿患者更常见(2.6%对1.6%;P < 0.01)。同样,脂肪性水肿患者发生VTE的情况比无脂肪性水肿患者更常见(0.6%对0.4%;P < 0.01)。经过多变量逻辑回归分析,肥胖合并淋巴水肿患者的VTE事件发生率高于无淋巴水肿患者(比值比1.6;可信区间1.08 - 2.43;P = 0.02)。同样,肥胖合并脂肪性水肿患者的VTE事件比无脂肪性水肿的肥胖患者更常见(比值比1.20;可信区间1.03 - 1.41;P = 0.02)。

结论

在这项生成假设的研究中,在调整了肥胖等基线患者特征(肥胖是已知的VTE独立危险因素)后,淋巴水肿和脂肪性水肿与VTE呈正相关。应研究淋巴水肿和脂肪性水肿与VTE相关的机制。

相似文献

1
Venous thromboembolic outcomes in patients with lymphedema and lipedema: An analysis from the National Inpatient Sample.淋巴水肿和脂肪性水肿患者的静脉血栓栓塞结局:来自全国住院患者样本的分析。
Vasc Med. 2024 Feb;29(1):42-47. doi: 10.1177/1358863X231219006.
2
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3.
3
Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.对无诱因静脉血栓栓塞症(VTE)患者进行癌症检测对癌症及VTE相关死亡率和发病率的影响。
Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD010837. doi: 10.1002/14651858.CD010837.pub3.
4
Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院内科和外科患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2013 Jul 16(7):CD008201. doi: 10.1002/14651858.CD008201.pub2.
5
Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.不明原因静脉血栓栓塞症(VTE)患者中,检测癌症对癌症或静脉血栓栓塞症(VTE)相关死亡率和发病率的影响。
Cochrane Database Syst Rev. 2021 Oct 1;10(10):CD010837. doi: 10.1002/14651858.CD010837.pub5.
6
Antiplatelet agents for the treatment of deep venous thrombosis.抗血小板药物治疗深静脉血栓形成。
Cochrane Database Syst Rev. 2022 Jul 25;7(7):CD012369. doi: 10.1002/14651858.CD012369.pub2.
7
Are Patients With Morbid Obesity at Increased Risk of Pulmonary Embolism or Proximal Deep Vein Thrombosis After Lower Limb Arthroplasty? A Large-database Study.肥胖症患者下肢关节置换术后发生肺栓塞或近端下肢深静脉血栓的风险是否增加?一项大数据库研究。
Clin Orthop Relat Res. 2024 Jan 1;482(1):115-124. doi: 10.1097/CORR.0000000000002742. Epub 2023 Jul 4.
8
Pentasaccharides for the prevention of venous thromboembolism.用于预防静脉血栓栓塞的五糖
Cochrane Database Syst Rev. 2016 Oct 31;10(10):CD005134. doi: 10.1002/14651858.CD005134.pub3.
9
High Risk of Venous Thromboembolism With Aspirin Prophylaxis After THA for High-riding Developmental Dysplasia of the Hip: A Retrospective, Comparative Study.髋关节高位发育性髋关节发育不良全髋关节置换术后阿司匹林预防静脉血栓栓塞的高风险:一项回顾性比较研究。
Clin Orthop Relat Res. 2025 Jun 9. doi: 10.1097/CORR.0000000000003482.
10
Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in patients with unprovoked VTE.对无诱因静脉血栓栓塞症(VTE)患者进行癌症检测对癌症及VTE相关死亡率和发病率的影响。
Cochrane Database Syst Rev. 2015 Mar 6(3):CD010837. doi: 10.1002/14651858.CD010837.pub2.

引用本文的文献

1
Lipedema: Progress, Challenges, and the Road Ahead.脂肪性水肿:进展、挑战与未来之路。
Obes Rev. 2025 Oct;26(10):e13953. doi: 10.1111/obr.13953. Epub 2025 May 27.
2
A Divergent Platelet Transcriptome in Patients with Lipedema and Lymphedema.脂肪水肿和淋巴水肿患者血小板转录组的差异性。
Genes (Basel). 2024 Jun 4;15(6):737. doi: 10.3390/genes15060737.